Surge Components, Inc. (SPRS)

Revance Therapeutics Income Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Revenue	32.96	31.21	36.28	51.91	39.83	31.72
Revenue Growth (YoY)	5.36%	-13.96%	-30.12%	30.34%	25.57%	-2.38%
Cost of Revenue	23.37	22.31	26.35	37.59	28.94	22.96
Gross Profit	9.59	8.9	9.93	14.32	10.89	8.75
Selling, General & Admin	8.59	7.93	8.35	9.52	7.66	7.23
Operating Expenses	8.66	8	8.42	9.6	7.73	7.27
Operating Income	0.93	0.9	1.51	4.72	3.15	1.48
Interest Expense	-	-	-	-0	-0	-0
Interest & Investment Income	0.36	0.33	0.11	-	-	-
Other Non Operating Income (Expenses)	-	-	-	0.19	0	0.02
EBT Excluding Unusual Items	1.3	1.24	1.63	4.91	3.15	1.5
Other Unusual Items	-	-	-	-	0.45	-
Pretax Income	1.3	1.24	1.63	4.91	3.6	1.5
Income Tax Expense	0.42	0.41	0.65	1.17	1.09	-0.01
Net Income	0.88	0.83	0.97	3.74	2.51	1.52
Preferred Dividends & Other Adjustments	0.01	0.01	0.01	0.01	0.01	0.01
Net Income to Common	0.87	0.82	0.97	3.73	2.51	1.51
Net Income Growth	389.88%	-15.06%	-73.98%	48.80%	65.59%	-25.48%
Shares Outstanding (Basic)	6	6	6	6	5	5
Shares Outstanding (Diluted)	6	6	6	6	6	6
Shares Change (YoY)	-0.28%	0.22%	0.18%	1.05%	2.58%	1.10%
EPS (Basic)	0.16	0.15	0.17	0.67	0.46	0.28
EPS (Diluted)	0.15	0.14	0.17	0.65	0.44	0.27
EPS Growth	401.42%	-17.65%	-73.85%	47.73%	62.96%	-27.03%
Free Cash Flow	0.19	1.81	2.15	2.19	2.13	1.14
Free Cash Flow Per Share	0.03	0.32	0.37	0.38	0.38	0.21
Gross Margin	29.10%	28.53%	27.37%	27.58%	27.33%	27.60%
Operating Margin	2.83%	2.90%	4.16%	9.10%	7.92%	4.68%
Profit Margin	2.64%	2.63%	2.67%	7.19%	6.29%	4.76%
Free Cash Flow Margin	0.58%	5.81%	5.92%	4.21%	5.35%	3.60%
EBITDA	1	0.97	1.58	4.8	3.22	1.52
EBITDA Margin	3.05%	3.12%	4.36%	9.25%	8.09%	4.80%
D&A For EBITDA	0.07	0.07	0.07	0.08	0.07	0.04
EBIT	0.93	0.9	1.51	4.72	3.15	1.48
EBIT Margin	2.83%	2.90%	4.16%	9.10%	7.92%	4.68%
Effective Tax Rate	32.47%	33.18%	40.20%	23.87%	30.32%	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.